Suggestions
Khalil Kadaoui
Head of Market Access and Public Affairs at Roche
Professional Background
Khalil Kadaoui is an accomplished professional in the healthcare industry, currently serving as the Head of Market Access and Public Affairs at Roche. With a wealth of experience spanning various roles in market access, pricing, and public affairs, Khalil has gained profound expertise in navigating complex regulatory landscapes and developing strategic initiatives that drive product access to patients worldwide. Before his current position, Khalil took on significant roles within the global pricing strategies at Roche, where he excelled as the Biologics Global Pricing Lead. His strategic vision and innovative mindset positioned him at the forefront of decision-making processes, ensuring that biologic therapies were appropriately valued and accessible to the healthcare systems.
Khalil's career footprint also includes stints at Amgen as a Senior Manager for Strategic Pricing and Contracting for the EMEA region, where he skillfully managed pricing strategies across multiple markets. His ability to adapt to diverse healthcare environments enabled him to devise effective pricing solutions that align with local payer expectations and value-based healthcare trends. Prior to that, Khalil held a pivotal role at Novartis, first as Associate Director of Pricing and Market Access for the AMAC region and later as Head of Market Access in Algeria. His contributions to Novartis also encompassed a range of positions, including Regional Brand Regulatory Manager and Post-Doctoral Fellow in Predictive Toxicology, further solidifying his vast understanding of the pharmaceutical landscape from regulatory to market access perspectives.
Education and Achievements
Khalil Kadaoui possesses an impressive academic background, having commenced his studies with a PhD at the University of Lausanne (UNIL). His doctoral studies contributed significantly to his depth of knowledge in healthcare, particularly in allergy and immunology, which he further enhanced while working as a Post-Doctoral Fellow at the University Hospital Lausanne within the Allergy-Immunology Division.
Additionally, Khalil pursued a Certificate at the University of Washington, where he expanded his understanding of market dynamics and access strategies. This diverse educational portfolio not only reflects his commitment to continuous learning but also highlights his ability to integrate academic research with applicable market strategies in the pharmaceuticals sector.
Notable Achievements
Throughout his extensive career, Khalil has made remarkable contributions to the healthcare industry, particularly in enhancing patient access to innovative therapies. His work at Roche has been instrumental in advancing market access frameworks that ensure equitable access to medications, reflecting his dedication to improving patient outcomes. Khalil's influence as a leader in market access is evidenced by his ability to develop pricing strategies that are not only sustainable from a business perspective but also consider the broader implications for healthcare systems and patients. His strategic insights have enabled companies to maintain compliance with evolving regulations while maximizing their market potential. Khalil's dedication to the healthcare industry and his expertise in market access are always geared toward creating a positive impact on patient lives. His collaborative approach and adept negotiation skills have garnered respect from peers and industry leaders alike, making him a valuable asset within any organization.
